Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus
In the last few decades through an awareness of transfusion transmitted infections (TTI), a majority of countries have mandated serology based blood screening assays for Human immunodeficiency virus (HIV), Hepatitis C virus (HCV), and Hepatitis B virus (HBV). However, despite improved serology assay...
Main Author: | Venkatakrishna Shyamala |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Asian Journal of Transfusion Science |
Subjects: | |
Online Access: | http://www.ajts.org/article.asp?issn=0973-6247;year=2014;volume=8;issue=1;spage=13;epage=18;aulast=Shyamala |
Similar Items
-
How Safe is Blood? A 5 Year Retrospective Study
by: Apra Kalra, et al.
Published: (2014-03-01) -
NATSpert ID TripleH: A novel individual donor multiplex nucleic acid amplification test to reduce risk of transfusion-transmitted infections: Two-year experience of a blood bank in central India
by: Sheela M Mundhada, et al.
Published: (2019-01-01) -
Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety
by: Rajesh Kumar, et al.
Published: (2015-01-01) -
Initial trends of individual donation nucleic acid testing in voluntary & replacement donors from a tertiary care centre in north India
by: Rekha Hans, et al.
Published: (2019-01-01) -
Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010
by: Kim Moon, et al.
Published: (2012-07-01)